Company Filing History:
Years Active: 2010-2015
Title: The Innovative Contributions of Jian-Xin Li
Introduction
Jian-Xin Li is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 3 patents. His work focuses on improving the properties of excipients used in tablet formulations, which are crucial for the effectiveness of solid dosage forms.
Latest Patents
One of Jian-Xin Li's latest patents is titled "Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations." This invention discloses a particulate co-processed composition that includes microcrystalline cellulose and at least one sugar alcohol, with mannitol being a preferred choice. The composition demonstrates an improved compactability profile, lubricant sensitivity, and ejection profile compared to the individual components. This advancement is particularly beneficial in the preparation of solid dosage formulations, such as tablets.
Another significant patent by Jian-Xin Li is related to "Latex or pseudolatex compositions, coatings and coating processes." This patent describes a composition that comprises at least one latex or pseudolatex water-insoluble film former, along with a permeation enhancing agent and optional plasticizers. The invention also covers substrates coated with this composition, films made from it, and methods for their preparation and use.
Career Highlights
Jian-Xin Li is currently employed at FMC Corporation, where he continues to innovate in the field of pharmaceutical excipients. His work has contributed to advancements in the formulation of tablets, enhancing their performance and efficacy.
Collaborations
Throughout his career, Jian-Xin Li has collaborated with esteemed colleagues, including Brian A C Carlin and Juergen Siepmann. These collaborations have further enriched his research and development efforts.
Conclusion
Jian-Xin Li's contributions to the field of pharmaceutical formulations through his innovative patents highlight his expertise and commitment to improving solid dosage forms. His work continues to influence the industry positively.